143TiPIMpower110: Phase III trial of 1L atezolizumab in PD-L1–selected chemotherapy-naive NSCLC. (3rd April 2017)

Record Type:: Journal Article
Title:: 143TiPIMpower110: Phase III trial of 1L atezolizumab in PD-L1–selected chemotherapy-naive NSCLC. (3rd April 2017)
Main Title:: 143TiPIMpower110: Phase III trial of 1L atezolizumab in PD-L1–selected chemotherapy-naive NSCLC
Authors:: Jassem, J.
de Marinis, F.
Spigel, D.R.
Lam, S.
Mocci, S.
Sandler, A.
Lopez-Chavez, A.
Deng, Y.
Giaccone, G.
Herbst, R.S.
Abstract:
Is Part Of:: Annals of oncology. Volume 28(2017)Supplement 2
Journal:: Annals of oncology
Issue:: Volume 28(2017)Supplement 2
Issue Display:: Volume 28, Issue 2 (2017)
Year:: 2017
Volume:: 28
Issue:: 2
Issue Sort Value:: 2017-0028-0002-0000
Page Start:
Page End:
Publication Date:: 2017-04-03
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdx091.063 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12629.xml